杜皮鲁玛
特应性皮炎
多药
医学
观察研究
皮肤病科
回顾性队列研究
单克隆
单克隆抗体
内科学
免疫学
抗体
作者
Maddalena Napolitano,Gabriella Fabbrocini,Massimiliano Scalvenzi,Chiara Blasio,Luca Stingeni,Cataldo Patruno
摘要
Atopic dermatitis (AD) is a common inflammatory skin disease with high prevalence in both children (15-30%) and adults (2-10%), but limited data are available for older people. Elderly patients form a challenging group, as multiple comorbidities, associated polypharmacy and failures with previous treatments are common. We performed a retrospective observational study on elderly (≥ 65 years) patients treated with dupilumab, monoclonal antibody to the shared alpha subunit of the interleukin-4 and -13 receptor approved for the treatment of moderate-to-severe AD in adults.
科研通智能强力驱动
Strongly Powered by AbleSci AI